Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG for GVHD Prophylaxis in MSD HSCT
NCT04203108Phase 4Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Sep 2019
- Primary completion
- Aug 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin in graft-versus-host disease (GVHD), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
antithymocyte globulin
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT04203108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04203108.